Trevi Therapeutics, Inc. TRVI Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s short-term investments?
- Trevi Therapeutics, Inc. (TRVI) reported short-term investments of $152.37M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s short-term investments changed year-over-year?
- Trevi Therapeutics, Inc.'s short-term investments increased by 81.6% year-over-year, from $83.88M to $152.37M.
- What is the long-term trend for Trevi Therapeutics, Inc.'s short-term investments?
- Over 3 years (2022 to 2025), Trevi Therapeutics, Inc.'s short-term investments has grown at a 16.2% compound annual growth rate (CAGR), from $107.92M to $169.35M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.